Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin

Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,260

Humoral Immunity Due to Long-Lived Plasma Cells

Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Sui, J., Hwang, W. C., Perez, S., Ge, W., Aird, D. R., Chen, L., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,128

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K. E., Larsen, C. P., Zheng, N., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,026

Highly Conserved Protective Epitopes on Influenza B Viruses

Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 857

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Wrammert, J., Koutsonanos, D., Li, G., Edupuganti, S., Sui, J., Michael, M., McCausland, M. M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge

van der Lubbe, J. E. M., Huizingh, J., Verspuij, J. W. A., Tettero, L., Schmit-Tillemans, S. P. R., Mooij, P., Mortier, D., Koopman, G., Bogers, W. M. J. M., Dekking, L., et al. (2018) · npj Vaccines · doi:10.1038/s41541-018-0063-7 · Cited by 26

Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards

Meade, P. S., Latorre‐Margalef, N., Stallknecht, D. E., & Krammer, F. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.98 · Cited by 25

Memory B‐cell diversity: From early generation to tissue residency and reactivation

Reusch, L., & Angeletti, D. (2023) · European Journal of Immunology · doi:10.1002/eji.202250085 · Cited by 27

Passive immunization with influenza haemagglutinin specific monoclonal antibodies

Rudraraju, R., & Subbarao, K. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1489947 · Cited by 25

Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection

Guo, Y., He, L., Song, N., Li, P., Sun, S., Zhao, G., Tai, W., Jiang, S., Du, L., & Zhou, Y. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2017.08.010 · Cited by 24

Role of Memory B Cells in Hemagglutinin-Specific Antibody Production Following Human Influenza A Virus Infection

Sangster, M. Y., Nguyen, P. Q. T., & Topham, D. J. (2019) · Pathogens · doi:10.3390/pathogens8040167 · Cited by 24

Influenza Immunization in the Context of Preexisting ImmunityPreprint

Linderman, S. L., Ellebedy, A. H., Davis, C. W., Eberhardt, C. S., Antia, R., Ahmed, R., & Zarnitsyna, V. I. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a040964 · Cited by 23

Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine

Yan, J., Morrow, M. P., Chu, J. S., Racine, T., Reed, C. C., Khan, A. S., Broderick, K. E., Kim, J. J., Kobinger, G. P., Sardesai, N. Y., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.086 · Cited by 23

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?

Matrajt, L., Halloran, M. E., & Antia, R. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz358 · Cited by 22

An antigen-specific, four-color, B-cell FluoroSpot assay utilizing tagged antigens for detection

Jahnmatz, P., Bengtsson, T., Zuber, B., Färnert, A., & Ahlborg, N. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.02.020 · Cited by 22

Immunizing the Immune: Can We Overcome Influenza’s Most Formidable Challenge?

Ellebedy, A. H. (2018) · Vaccines · doi:10.3390/vaccines6040068 · Cited by 22

Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays

Köppert, S., Wolf, C., Becza, N., Sautto, G. A., Franke, F., Küerten, S., Ross, T. M., Lehmann, P., & Kirchenbaum, G. A. (2021) · Cells · doi:10.3390/cells10081843 · Cited by 19

An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model

Clemens, E. A., Holbrook, B. C., Kanekiyo, M., Yewdell, J. W., Graham, B. S., & Alexander‐Miller, M. A. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa728 · Cited by 21

Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice

Hawman, D. W., Tipih, T., Hodge, E., Stone, E. T., Warner, N., McCarthy, N., Granger, B., Meade-White, K., Leventhal, S., Hatzakis, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55546-7 · Cited by 20

Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination

Tete, S. M., Krammer, F., Lartey, S. L., Bredholt, G., Wood, J., Skrede, S., & Cox, R. J. (2016) · npj Vaccines · doi:10.1038/npjvaccines.2016.1 · Cited by 20

A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza

DiPiazza, A. T., Fan, S., Rattan, A., DeDiego, M. L., Chaves, F. A., Neumann, G., Kawaoka, Y., & Sant, A. J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900819 · Cited by 20

Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines

Jegaskanda, S., Andrews, S. F., Wheatley, A. K., Yewdell, J. W., McDermott, A. B., & Subbarao, K. (2019) · JCI Insight · doi:10.1172/jci.insight.129035 · Cited by 20

H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model

Carreño, J. M., Strohmeier, S., Roubidoux, E. K., Hai, R., Palese, P., & Krammer, F. (2020) · mBio · doi:10.1128/mbio.02090-20 · Cited by 20

An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice

Kim, E. S., Han, G.-Y., & Nguyen, H. H. (2017) · Viruses · doi:10.3390/v9080234 · Cited by 19

Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection

Zhou, F., Hansen, L., Pedersen, G. K., Grødeland, G., & Cox, R. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.747774 · Cited by 20

Pre-existing neutralizing antibodies against cattle-transmitted influenza A virus H5N1 are detectable in unexposed individuals

Daniel, K., Ullrich, L., Ruchnewitz, D., Meijers, M., Halwe, N. J., Wild, U., Eberhardt, J., Schön, J., Stumpf, R., Schlotz, M., et al. (2026) · Immunity · doi:10.1016/j.immuni.2025.12.013 · Cited by 17

Respiratory virus-induced heterologous immunity

Pusch, E., Renz, H. E., & Skevaki, C. L. (2018) · Allergo Journal International · doi:10.1007/s40629-018-0056-0 · Cited by 18

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers

Hansen, L., Zhou, F., Amdam, H., Trieu, M.-C., & Cox, R. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.748264 · Cited by 18

Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination

Islam, S., Mohn, K. G.-I., Krammer, F., Sanne, M., Bredholt, G., Jul‐Larsen, Å., Tete, S. M., Zhou, F., Brokstad, K. A., & Cox, R. J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.044 · Cited by 17

An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses

Hong, J. P., Reynoso, G. V., Andhey, P. S., Swain, A., Turner, J. S., Boon, A. C. M., Krammer, F., Ellebedy, A. H., Zanini, F., Artyomov, M. N., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100035 · Cited by 17

The recent advancements in protein nanoparticles for immunotherapy

Xu, M., Wei, S., Duan, L., Ji, Y., Han, X., Sun, Q., & Weng, L. (2024) · Nanoscale · doi:10.1039/d4nr00537f · Cited by 19

Antiviral Vaccines: Challenges and Advances

Ellebedy, A. H., & Ahmed, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802174-3.00015-1 · Cited by 19

Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity

Wheatley, A. K., & Kent, S. J. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1068125 · Cited by 17

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses

McMillan, C. L. D., Cheung, S. T. M., Modhiran, N., Barnes, J., Amarilla, A. A., Bielefeldt‐Ohmann, H., Lee, L., Guilfoyle, K. A., van Amerongen, G., Stittelaar, K. J., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00395-4 · Cited by 16

Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease

Luo, Z., Miranda, H. A., Burke, K. N., Spurrier, M. A., Berry, M., Stover, E. L., Spreng, R. L., Waitt, G. M., Soderblom, E. J., Macintyre, A. N., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj4685 · Cited by 16

Seasonal Influenza Vaccination Is the Strongest Correlate of Cross-Reactive Antibody Responses in Migratory Bird Handlers

Oshansky, C. M., Wong, S., Jeevan, T., Smallwood, H. S., Webby, R. J., Shafir, S., & Thomas, P. G. (2014) · mBio · doi:10.1128/mbio.02107-14 · Cited by 16

A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques

Florek, K. R., Kamlangdee, A., Mutschler, J. P., Kingstad-Bakke, B. A., SCHULTZ‐DARKEN, N. J., Broman, K. W., Osorio, J. E., & Friedrich, T. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181738 · Cited by 16

Identification of a broad-inhibition influenza neuraminidase antibody from pre-existing memory B cells

Wang, X., Kong, H., Chu, B., Yang, Q., Lin, C., Liu, R., Chen, C., Gao, Y., Wang, G., Wang, D., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.12.004 · Cited by 15

Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human

Yamayoshi, S., Ito, M., Uraki, R., Sasaki, T., Ikuta, K., & Kawaoka, Y. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.12.004 · Cited by 15

Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines

Petrie, J. G., & Gordon, A. L. (2018) · Vaccines · doi:10.3390/vaccines6020017 · Cited by 15

Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity

Labombarde, J. G., Pillai, M. R., Wehenkel, M., Lin, C.-Y., Keating, R., Brown, S. A., Crawford, J. C., Brice, D. C., Castellaw, A. H., Mandarano, A. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110482 · Cited by 20

A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity

Kaugars, K. E., Dardick, J. M., de Oliveira, A. P., Weiss, K. A., Lukose, R., Kim, J., Leung, L. W., Saranathan, R., Wolin, S., Akabas, L. H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110714118 · Cited by 14

Highly pathogenic avian influenza (HPAI) H5 virus exposure in domestic cats and rural stray cats, the Netherlands, October 2020 to June 2023

Duijvestijn, M. B. H. M., Schuurman, N., Vernooij, J. C. M., van Leeuwen, M. A. J. M., van den Brand, J. M. A., Wagenaar, J. A., van Kuppeveld, F. J. M., Egberink, H. F., de Haan, C. A. M., & Verhagen, J. H. (2024) · Eurosurveillance · doi:10.2807/1560-7917.es.2024.29.44.2400326 · Cited by 14

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains

Lartey, S. L., Pathirana, R. D., Zhou, F., Jul‐Larsen, Å., Montomoli, E., Wood, J., & Cox, R. J. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1048939 · Cited by 14

Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity

DiPiazza, A. T., Richards, K. A., Poulton, N. C., & Sant, A. J. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00548-16 · Cited by 14

Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness

Dhar, N., Kwatra, G., Nunes, M. C., Cutland, C., Izu, A., Nachbagauer, R., Krammer, F., & Madhi, S. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz927 · Cited by 14

Targeting Viral Surface Proteins through Structure-Based Design

Narkhede, Y. B., Gonzalez, K. J., & Strauch, E. (2021) · Viruses · doi:10.3390/v13071320 · Cited by 15

Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children

Yegorov, S., Celeste, D. B., Gomes, K. B., Ang, J. C., Vandenhof, C., Wang, J., Rybkina, K., Tsui, V., Stacey, H. D., Loeb, M. B., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100509 · Cited by 13

Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic

Hoa, L. N. M., Mai, L. Q., Bryant, J. E., Thái, P. Q., Hằng, N. L. K., Yen, N. T. T., Dương, T. N., Thoang, D. D., Horby, P., Werheim, H. F. L., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00093-16 · Cited by 13

Respiratory virus-induced heterologous immunity

Pusch, E., Renz, H. E., & Skevaki, C. L. (2018) · Allergo Journal · doi:10.1007/s15007-018-1580-4 · Cited by 13

Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains

Wang, J., Li, D., Perry, S., Hilchey, S. P., Wiltse, A., Treanor, J. J., Sangster, M. Y., & Zand, M. S. (2021) · mBio · doi:10.1128/mbio.00449-21 · Cited by 13

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies

Carreño, J. M., McDonald, J. U., Hurst, T. P., Rigsby, P., Atkinson, E., Charles, L., Nachbagauer, R., Behzadi, M. A., Strohmeier, S., Coughlan, L., et al. (2020) · Vaccines · doi:10.3390/vaccines8040666 · Cited by 12

Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it

Wang, W., Vassell, R. A., Song, H. S., Qiong, C., Keller, P. W., Verma, S., Alvarado-Facundo, E., Wan, H., Schmeisser, F., Meseda, C. A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222436 · Cited by 12

Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge

Jang, H., Meyers, L. M., Boyle, C., Groot, A. S. D., Moise, L., & Ross, T. M. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1793711 · Cited by 12

Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genes

Lin, T.-H., Lee, C.-C. D., Fernández‐Quintero, M. L., Ferguson, J. A., Han, J., Zhu, X., Yu, W., Guthmiller, J. J., Krammer, F., Wilson, P. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56496-4 · Cited by 12

Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity

Desikan, R., Linderman, S. L., Davis, C. W., Zarnitsyna, V. I., Ahmed, H., & Antia, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985478 · Cited by 13

Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?

Stadlbauer, D., Nachbagauer, R., Meade, P. S., & Krammer, F. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0602-z · Cited by 11

Immune memory shapes human polyclonal antibody responses to H2N2 vaccination

Yang, Y. R., Han, J., Perrett, H. R., Richey, S. T., Rodriguez, A. J., Jackson, A. M., Gillespie, R. A., O’Connell, S. E., Raab, J. E., Cominsky, L. Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114171 · Cited by 10

Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem–specific human B cells

Mantus, G. E., Chopde, A. J., Gorman, J., Cominsky, L. Y., Ourahmane, A., Creanga, A., Shimberg, G. D., Gillespie, R. A., Wazer, D. J. V., Zhou, T., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr8373 · Cited by 10

Atypical antibody responses to influenza

Hermans, D., Webby, R. J., & Wong, S. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.12.122 · Cited by 10

Functional heterogeneity in the memory B-cell response

Henry, B., & Laidlaw, B. J. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102281 · Cited by 10

Understanding immune responses to the influenza vaccine

Webby, R. J. (2016) · Nature Medicine · doi:10.1038/nm.4248 · Cited by 10

Toward universal influenza virus vaccines: from natural infection to vaccination strategy

Zhao, C., & Xu, J. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.020 · Cited by 10

Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection

Kavian, N., Hachim, A., Poon, L. L. M., & Valkenburg, S. A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.008 · Cited by 10

Research Progress of Universal Influenza Vaccine

Wang, L., Xie, Q., Yu, P., Zhang, J., He, C., Huang, W., Wang, Y., & Zhao, C. (2025) · Vaccines · doi:10.3390/vaccines13080863 · Cited by 8

Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2

Changrob, S., Yasuhara, A., Park, S., Bangaru, S., Li, L., Troxell, C. A., Halfmann, P., Erickson, S. A., Catanzaro, N., Yuan, M., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20251146 · Cited by 9

Primary antibody response after influenza virus infection is first dominated by low-mutated HA-stem antibodies followed by higher-mutated HA-head antibodies

Aartse, A., Mortier, D., Mooij, P., Hofman, S., van Haaren, M. M., Corcoran, M., Hedestam, G. B. K., Eggink, D., Claireaux, M. A. F., Bogers, W. M. J. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1026951 · Cited by 12

Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing

Jaishwal, P., Jha, K., & Singh, S. P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134012 · Cited by 10

Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine

Tete, S. M., Jul‐Larsen, Å., Rostami, S., Lunde, T. H. F., Søland, H., Krammer, F., & Cox, R. J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.022 · Cited by 9

Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses

Wang, W.-C., Sayedahmed, E. E., Alhashimi, M., Elkashif, A., Gairola, V., Murala, M. S. T., Sambhara, S. R., & Mittal, S. K. (2025) · Vaccines · doi:10.3390/vaccines13010095 · Cited by 8

Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies

Fischer, A. A. M., Corcoran, M., Brouwer, P. J. M., Chernyshev, M., Gillespie, R. A., Nicoletto, A., Loeffler, J. R., Ferguson, J. A., Zygouras, I., Pushparaj, P., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.03.002 · Cited by 10

Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages

Vandoorn, E., Parys, A., Chepkwony, S., Chiers, K., & Reeth, K. V. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.051 · Cited by 8

Co‐Delivery of Multiple Toll‐Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy

Ramírez, A. G., Hernandez‐Davies, J. E., Jain, A., Wang, L., Strahsburger, E., Davies, D. H., & Wang, S. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404335 · Cited by 8

Pandemic influenza vaccines: what they have taught us about B cell immunology

Topham, D. J., Nguyen, P. Q. T., & Sangster, M. Y. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.06.004 · Cited by 8

Influenza – A new pathogen every year

Abreu, R. B., & Ross, T. M. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.08.011 · Cited by 8

Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+T Cell ActivationIn Vitrobut Not in C57BL/6 Mice

Altenburg, A. F., van de Sandt, C. E., Trierum, S. E. V.-V., Gruyter, H. L. M. D., van Run, P. R. W. A., Fouchier, R. A. M., Roose, K., Saelens, X., Volz, A., Sutter, G., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01633-16 · Cited by 8

Quantifying the shifting landscape of B cell immunodominance

Dale, G. A., Shartouny, J. R., & Jacob, J. (2017) · Nature Immunology · doi:10.1038/ni.3695 · Cited by 8

Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice

Altenburg, A. F., Magnusson, S. E., Bosman, F., Stertman, L., de Vries, R. D., & Rimmelzwaan, G. F. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13004 · Cited by 8

A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection

Li, Y., Xu, M., Li, Y., Gu, W., Halimu, G., Li, Y., Zhang, Z., Zhou, L., Liao, H., Yao, S., et al. (2021) · eLife · doi:10.7554/elife.71725 · Cited by 7

Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?

Sun, C., & Wiestner, A. U. (2021) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2021.03.010 · Cited by 8

Assessment of Influenza Virus Hemagglutinin Stalk-Specific Antibody Responses

Liu, W., Nachbagauer, R., Krammer, F., & Albrecht, R. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8678-1_23 · Cited by 6

Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies

Keating, R., Johnson, J. L., Brice, D. C., Labombarde, J. G., Dent, A. L., & McGargill, M. A. (2020) · mBio · doi:10.1128/mbio.01859-20 · Cited by 7

A Coarse-Grained Model of Affinity Maturation Indicates the Importance of B-Cell Receptor Avidity in Epitope Subdominance

Ovchinnikov, V., & Karplus, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.816634 · Cited by 6

How a well-adapting immune system remembersPreprint

Mayer, A., Balasubramanian, V., Walczak, A. M., & Mora, T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/347856 · Cited by 7

Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice

Kil, L. P., Vaneman, J., van der Lubbe, J. E. M., Czapska-Casey, D. N., Tolboom, J. T. B. M., Roozendaal, R., Zahn, R. C., Kuipers, H., & Solforosi, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225063 · Cited by 5

Seasonal influenza vaccines and hurdles to mutual protection

Chiu, C. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.03.021 · Cited by 5

Brief Comparison of Novel Influenza Vaccine Design Strategies

Chai, S., Ye, C., Fan, C., & Jiang, H. X. (2025) · Vaccines · doi:10.3390/vaccines13111164 · Cited by 6

Low‐level human memory T and B cells recognising avian influenza hemagglutinins are poorly responsive to existing seasonal influenza vaccines

Gonelli, C. A., Koutsakos, M., Esterbauer, R., Zheng, M. Z. M., Liu, Y., Zin, A. K., Schwab, L. S. U., Hurt, A. C., Kent, S. J., Juno, J. A., et al. (2025) · Clinical & Translational Immunology · doi:10.1002/cti2.70067 · Cited by 4

Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen

Verhoeven, D. E., Sponseller, B. A., Crowe, J. E., Bangaru, S., Webby, R. J., & Lee, B. M. (2024) · npj Vaccines · doi:10.1038/s41541-024-01037-1 · Cited by 4

M2e/NP Dual Epitope-Displaying Nanoparticles Enhance Cross-Protection of Recombinant HA Influenza Vaccine: A Universal Boosting Strategy

Liu, R., Yang, L., Feng, J., Zhang, S., Wu, L., Du, Y., De, K., Xu, Y., & Peng, T. (2025) · Vaccines · doi:10.3390/vaccines13040412 · Cited by 4

Highly variable antigenic site located at the apex of GII.4 norovirus capsid protein induces cross-reactive blocking antibodies in a variant-specific manner

Landivar, M., Tohma, K., Pilewski, K. A., Ford-Siltz, L. A., Kendra, J. A., Gao, Y. S., & Parra, G. I. (2025) · Journal of Virology · doi:10.1128/jvi.00652-25 · Cited by 4

A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutininPreprint

Guthmiller, J. J., Han, J., Utset, H. A., Li, L., Lan, L. Y.-L., Henry, C., Stamper, C. T., Stovicek, O., Gentles, L. E., Dugan, H. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.25.432905 · Cited by 4

Preclinical evaluation of an mRNA vaccine developed from the first human isolate of bovine H5N1

Li, H., Huang, M., Feng, S., Li, W., Wei, D., Li, X., Quan, Y., Gu, H. S., Jiang, T., Liu, Y., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102702 · Cited by 4

Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques

Styles, T. M., Akhtar, A., Gu, C., Neumann, G., Muramatsu, H., McPartlan, J. S., Talukder, P., Gratz, D., Stokdyk, K., Turner, H. L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102369 · Cited by 3

Affinity maturation and light-chain-mediated paratope diversification anticipates viral evolution

Dingus, J. G., Yoo, D. K., Kumar, S., Wang, Y., Kibria, M. G., Saghaei, S., Allahyari, Z., Chen, J. W., Caputo, N., Hwang, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116800 · Cited by 3

Universal Influenza Vaccine Design: Directing the Antibody Repertoire

Cox, F., Juraszek, J., Stoop, E. J. M., & Goudsmit, J. (2016) · Future Virology · doi:10.2217/fvl-2016-0045 · Cited by 3

Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine

Ferdman, J., Palladino, G., Liao, H., Moody, M. A., Kepler, T. B., Giudice, G. D., Dormitzer, P. R., Harrison, S. C., Settembre, E. C., & Suphaphiphat, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.054 · Cited by 3

Detection of Cross-Reactive B Cells Using the FluoroSpot Assay

Jahnmatz, P., & Ahlborg, N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8567-8_6 · Cited by 3

Pretreatment of outer membrane vesicle and subsequent infection with influenza virus induces a long-lasting adaptive immune response against broad subtypes of influenza virus

Kim, C.-U., Eo, S.-K., Lee, P., Kim, S., Kim, Y. S., & Kim, D. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104878 · Cited by 3

Modulation of B cell receptor activation by antibody competition

He, Y., Guo, Z., & Vahey, M. D. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115944 · Cited by 3

Delineation of the antibody light chain biases and kinetics following primary and secondary influenza virus infections of ferrets

Richardson, R. A., Rowe, T., Kirchenbaum, G. A., Zhang, X., Shi, H., Sautto, G. A., & Ross, T. M. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlaf085 · Cited by 2

Seven decades after the Asian influenza pandemic: A historical review about immunity and vaccines against H2N2

Tscherne, A., & Krammer, F. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128467 · Cited by 2

Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection

Mooij, P., Mortier, D., Aartse, A., Murad, A. B., Correia, R., Roldão, A., Alves, P. M., Fagrouch, Z. C., Eggink, D., Stockhofe, N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1256094 · Cited by 2

Induction of enhanced stem-directed neutralizing antibodies by HA2-16 ferritin nanoparticles with H3 influenza virus boost

Wang, Q., Nie, J., Liu, Z., Chang, Y., Wei, Y., Yao, X., Sun, L., Liu, X., Liu, Q., Liang, X., et al. (2025) · Nanoscale Advances · doi:10.1039/d4na00964a · Cited by 2

Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response

Liu, C., Ru, Y.-X., Li, H.-R., Liu, D., Liu, J., Zhao, S.-L., Wu, X., Peng, Y., Li, Y., & Deng, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142240 · Cited by 2

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Li, G.-M., Chiu, C., Wrammert, J., McCausland, M. M., Andrews, S. F., Zheng, N., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393

Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination

Wei, C., Boyington, J. C., McTamney, P. M., Kong, W., Pearce, M. B., Xu, L., Andersen, H., Rao, S. S., Tumpey, T. M., Yang, Z., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337

A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

Andrews, S. F., Raab, J. E., Gorman, J., Gillespie, R. A., Cheung, C. S. F., Rawi, R., Cominsky, L. Y., Boyington, J. C., Creanga, A., Shen, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01636-8 · Cited by 43

An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans

Andrews, S. F., Cominsky, L. Y., Shimberg, G. D., Gillespie, R. A., Gorman, J., Raab, J. E., Brand, J., Creanga, A., Gajjala, S. R., Narpala, S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4976 · Cited by 77

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem

Thomson, C. A., Wang, Y., Jackson, L. M., Olson, M., Wang, W., Liavonchanka, A., Keleta, L., da Silva, V. G. L., Diederich, S., Jones, R. B., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00087 · Cited by 109